Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.
Sabin J, Salas E, Martín-Martínez J, Candeliere-Merlicco A, Barrero Hernández FJ, Alonso Torres AM, Sánchez-Menoyo JL, Borrega L, Rodríguez-Rodríguez M, Gómez-Gutiérrez M, Eichau S, Hernández-Pérez MÁ, Calles C, Fernandez-Diaz E, Carmona O, Orviz A, López-Real A, López-Muñoz P, Mendoza Rodríguez A, Aguera-Morales E, Maurino J. Sabin J, et al. Among authors: lopez real a. Patient Prefer Adherence. 2024 Jun 7;18:1163-1171. doi: 10.2147/PPA.S459242. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 38863945 Free PMC article.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Arnal-García C, Amigo-Jorrin Mdel C, López-Real AM, Lema-Devesa C, Llopis N, Sanchez-de la Rosa R; XPERIENCIA-5 Study Group. Arnal-García C, et al. J Clin Neurosci. 2014 Dec;21(12):2212-8. doi: 10.1016/j.jocn.2014.05.045. Epub 2014 Sep 23. J Clin Neurosci. 2014. PMID: 25257663
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale.
Sabin J, Salas E, Martín-Martínez J, Candeliere-Merlicco A, Barrero FJ, Alonso A, Sánchez-Menoyo JL, Borrega L, Rodríguez-Rodríguez M, Gómez-Gutiérrez M, Eichau S, Hernández-Pérez MÁ, Calles C, Fernández-Díaz E, Carmona O, Orvíz A, López-Real A, López-Muñoz P, Mendoza A, Agüera E, Maurino J, Ballesteros J. Sabin J, et al. Among authors: lopez real a. Mult Scler J Exp Transl Clin. 2024 Apr 18;10(2):20552173241247680. doi: 10.1177/20552173241247680. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38638273 Free PMC article.
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.
Oreja-Guevara C, Meca-Lallana JE, Díaz-Díaz J, Ara JR, Hernández Pérez MÁ, Gracia Gil J, Alonso Torres AM, Pilo de la Fuente B, Ramió-Torrentà L, Eichau Madueño S, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Aguado Valcárcel M, Martínez Ginés ML, El Berdei Montero Y, López Real AM, González-Quintanilla V, De Torres L, Martínez-Rodríguez JE, Costa-Frossard L, Garcés Redondo M, Labiano Fontcuberta A, Castellanos-Pinedo F, García Merino JA, Muñoz Fernández C, Castillo-Triviño T, Meca-Lallana V, Peña Martínez J, Rodríguez-Antigüedad A, Prieto González JM, Agüera Morales E, Pérez Molina I, Solar Sánchez DM, Herrera Varo N, Romero Sevilla R, Gómez Vicente L, Río J. Oreja-Guevara C, et al. Among authors: lopez real am. Mult Scler Relat Disord. 2024 Oct;90:105787. doi: 10.1016/j.msard.2024.105787. Epub 2024 Aug 2. Mult Scler Relat Disord. 2024. PMID: 39142050 Free article.
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis.
Sabin J, Salas E, Martín-Martínez J, Candeliere-Merlicco A, Barrero FJ, Alonso A, Sánchez-Menoyo JL, Borrega L, Rodríguez-Rodríguez M, Gómez-Gutiérrez M, Eichau S, Hernández-Pérez MÁ, Calles C, Fernández-Díaz E, Carmona O, Orviz A, López-Real A, López-Muñoz P, Mendonza A, Agüera E, Maurino J. Sabin J, et al. Among authors: lopez real a. Mult Scler Relat Disord. 2024 Nov;91:105861. doi: 10.1016/j.msard.2024.105861. Epub 2024 Sep 3. Mult Scler Relat Disord. 2024. PMID: 39265268 Free article.
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Gracia-Gil J, Fernández E, Meca-Lallana V, Díaz-Pérez C, Sainz de la Maza S, Pacheco EM, Quiroga A, Ramió-Torrentà L, Martínez-Yélamos S, Bau L, Monreal E, López-Real A, Rodero-Romero A, Borrega L, Díaz S, Eguía P, Espiño M, Chico-García JL, Barrero FJ, Martínez-Ginés ML, García-Domínguez JM, De la Fuente S, Moreno I, Sainz-Amo R, Mañé-Martínez MA, Caminero A, Castellanos F, Gómez López A, Labiano-Fontcuberta A, Ayuso L, Abreu R, Hernández MÁ, Meca-Lallana J, Martín-Aguilar L, Muriel García A, Masjuan J, Costa-Frossard L, Villar LM. Rodríguez-Jorge F, et al. Among authors: lopez real a. Front Immunol. 2024 Nov 12;15:1480676. doi: 10.3389/fimmu.2024.1480676. eCollection 2024. Front Immunol. 2024. PMID: 39606235 Free PMC article.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Meca-Lallana JE, Prieto González JM, Caminero Rodríguez AB, Olascoaga Urtaza J, Alonso AM, Durán Ferreras E, Espinosa R, Dotor J, Romera M, Ares Luque A, Pérez Ruiz D, Calles C, Hernández MA, Hervás García M, Mendoza Rodríguez A, Berdei Montero Y, Téllez N, Herrera Varó N, Sotoca J, Presas-Rodríguez S, Querol Gutierrez LA, Hervás Pujol M, Batlle Nadal J, Martín Ozaeta G, Gubieras Lillo L, Martínez Yélamos S, Ramió-Torrentà L, Mallada Frechin J, Belenguer Benavides A, Gascón-Giménez F, Casanova B, Landete Pascual L, Berenguer L, Navarro L, Gómez Gutierrez M, Durán C, Rodríguez Regal A, Álvarez E, García-Estévez DA, López Real AM, Llaneza González MA, Marzo Sola ME, Sánchez-Menoyo JL, Oterino A, Villaverde González R, Castillo-Triviño T, Álvarez de Arcaya A, Llarena C. Meca-Lallana JE, et al. Among authors: lopez real am. Neurol Ther. 2023 Dec;12(6):2177-2193. doi: 10.1007/s40120-023-00557-7. Epub 2023 Oct 20. Neurol Ther. 2023. PMID: 37861931 Free PMC article.
Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.
López-Real AM, Gonzalez I, Solar DM, Oterino A, Costa E, Pato A, Llaneza MA, García-Estévez DA, Rodriguez-Regal A, Rodriguez M, Peña J. López-Real AM, et al. Mult Scler Relat Disord. 2023 Jul;75:104762. doi: 10.1016/j.msard.2023.104762. Epub 2023 May 13. Mult Scler Relat Disord. 2023. PMID: 37229800
[Multiple sclerosis and fatigue. It is necessary to improve].
Formigo Couceiro J, López Real AM. Formigo Couceiro J, et al. Among authors: lopez real am. Rehabilitacion (Madr). 2023 Apr-Jun;57(2):100747. doi: 10.1016/j.rh.2022.05.004. Epub 2022 Nov 5. Rehabilitacion (Madr). 2023. PMID: 36347657 Spanish. No abstract available.
23 results